5-HT1A Serotonin Receptor

480  relevant articles (22 outcomes, 75 trials/studies) found for this Bio-Agent

Receptor, Serotonin, 5-HT1A; 5-HT(1A) Receptor; 5-HT1A Receptor; 5-Hydroxytryptamine 1A Receptor; 5-Hydroxytryptamine 1A Receptors; Receptor, 5-Hydroxytryptamine 1A; Serotonin Receptor, 5-HT1A; Serotonin, 5-HT1a Receptor; 1A Receptor, 5-Hydroxytryptamine; 1A Receptor, Serotonin; 1A Receptors, 5-Hydroxytryptamine; 5 HT1A Receptor; 5 Hydroxytryptamine 1A Receptor; 5 Hydroxytryptamine 1A Receptors; 5-HT1a Receptor Serotonin; Receptor Serotonin, 5-HT1a; Receptor, 5 Hydroxytryptamine 1A; Receptor, 5-HT1A; Receptor, 5-HT1A Serotonin; Receptor, Serotonin 1A; Receptors, 5-Hydroxytryptamine 1A; Serotonin Receptor, 5 HT1A; Serotonin, 5 HT1a Receptor; Serotonin 1A Receptor

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Colpaert, Francis C: 6 articles (07/2007 - 10/2002)
2.	Grasby, Paul M: 3 articles (09/2008 - 09/2004)
3.	Bishop, Christopher: 3 articles (07/2008 - 05/2006)
4.	Eskow, Karen L: 3 articles (07/2008 - 05/2006)
5.	Hietala, Jarmo: 3 articles (06/2008 - 04/2004)
6.	Kajander, Jaana: 3 articles (06/2008 - 04/2004)
7.	Någren, Kjell: 3 articles (06/2008 - 04/2004)
8.	Drevets, Wayne C: 3 articles (03/2008 - 09/2005)
9.	Kline, Anthony E: 3 articles (02/2007 - 11/2002)
10.	Zafonte, Ross D: 3 articles (02/2007 - 11/2002)

Related Diseases

1.	Brain Injuries (Brain Injury) 05/01/2002 - "They also indicate that injury-induced changes in the 5-HT1A receptor may contribute to traumatic brain injury-induced cognitive deficits." 01/01/2001 - "The selective 5-HT(1A) receptor agonist repinotan HCl attenuates histopathology and spatial learning deficits following traumatic brain injury in rats." 01/01/2001 - "findings extend the therapeutic efficacy of Repinotan HCl to a contusion model of experimental brain injury and demonstrate for the first time that 5-HT(1A) receptor agonists confer neuroprotection and attenuate spatial learning deficits following controlled cortical impact injury" 04/01/2005 - "Neuroprotective efficacy of repinotan HCl, a 5-HT1A receptor agonist, in animal models of stroke and traumatic brain injury." 04/01/2005 - "Repinotan is a highly potent 5-HT1A receptor agonist with strong neuroprotective efficacy in animal models of middle cerebral artery occlusion and traumatic brain injury" Get all the results and reference details, order at left...
2.	Schizophrenia (Dementia Praecox) 12/16/2008 - "Further study is needed to determine the role of the 5-HT(1A) receptor to improve cognitive function in schizophrenia." 12/01/2006 - "BACKGROUND: Postmortem and positron emission tomography (PET) studies have reported several alterations in serotonin 1A receptor (5-HT(1A)) binding parameters in patients with schizophrenia" 03/01/2001 - "In patients with schizophrenia, the majority of post-mortem studies have reported increases in 5-HT1A receptor density in the prefrontal cortex in the approximate range 15-80%" 07/01/2000 - "The above results of preclinical investigations indicate that 5-HT1A receptor can be involved in the pathology of schizophrenia, what is partly confirmed by clinical postmortem studies of schizophrenic brains" 12/01/2006 - "This raises the question as to whether major changes in the level of expression of the 5-HT(1A) receptor play a role in the pathophysiology of schizophrenia." Get all the results and reference details, order at left...
3.	Pain (Aches) 01/01/1989 - "Although further studies are required, these preliminary data support 5-HT1A receptor involvement in the mediation of this form of adaptive pain inhibition." 10/03/2007 - "Correlation of human cold pressor pain responses with 5-HT(1A) receptor binding in the brain." 03/27/2006 - "Following medial medullary administration of a 5-HT(1A) receptor antagonist, descending pain regulatory pathways are disinhibited" 01/01/2006 - "5-HT(1A) receptor activation: new molecular and neuroadaptive mechanisms of pain relief." 09/28/2005 - "These results suggest that low frequency EA can relieve inflammatory pain in CIA and the analgesic effect of EA can be mediated by muscarinic cholinergic receptor, 5-HT1a and 5-HT3 receptors, but not by 5-HT2 receptor." Get all the results and reference details, order at left...
4.	Anxiety Disorders (Anxiety Disorder) 07/05/2008 - "Association study between the serotonin 1A receptor (HTR1A) gene and neuroticism, major depression, and anxiety disorders." 05/01/2007 - "The objective of this study was to investigate 5-HT1A receptor binding potential (BP) in social anxiety disorder (SAD)" 11/21/2008 - "Changes in 5-HT(1A) receptor-mediated neurotransmission at the level of the median raphe nucleus (MRN) are reported to affect the expression of defensive responses that are associated with generalized anxiety disorder (e.g" 01/01/2006 - "BACKGROUND: Azapirones are a group of drugs that work at the 5-HT1A receptor and are used to treat patients suffering from generalized anxiety disorder (GAD)" 07/01/2004 - "The expression level of the 5-HT(1A) receptor gene (htr1a) in the central nervous system (CNS) is implicated in the aetiology and treatment of anxiety disorders and depression" Get all the results and reference details, order at left...
5.	Syndrome 06/01/1999 - "This further demonstrates that the reversal of this aspect of the olfactory bulbectomy-induced behavioral syndrome is insensitive to the potential faster onset of antidepressant action induced by 5-HT1A receptor antagonists" 01/01/1996 - "These analyses will yield new insights into the possible mechanisms down-regulation of 5-HT1A receptor signaling, and may suggest novel sites of inherent defect involved in anxiety syndromes or major depression." 01/26/1993 - "The behavioural syndrome and the hypothermia were antagonized by the 5-HT1A receptor antagonist, (S)-UH-301" 07/01/2001 - "In behavioral studies, 12-14 and 16 behaved like postsynaptic 5-HTIA receptor antagonists, since they reduced lower lip retraction and the behavioral syndrome induced by 8-OH-DPAT (5-HT1A receptor agonist) in rats" 04/01/2005 - "The serotonin behavioral syndrome, which includes hyperlocomotion, was assessed in both groups of rats after escalating doses of the 5-HT(1A) receptor agonist 8-hydroxy(di-n-propylamine)tetralin (8-OH DPAT)" Get all the results and reference details, order at left...
132 Diseases and 480 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Serotonin (5 Hydroxytryptamine)
2.	8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)
3.	5-HT1A Serotonin Receptor
4.	F 13640
5.	Fluoxetine (Prozac)
6.	Buspirone (Buspar)
7.	hydroxide ion
8.	Serotonin Uptake Inhibitors (Serotonin Reuptake Inhibitors)
9.	Ligands
10.	N-Methylaspartate (NMDA)
261 Drugs and Important Bio-Agents and 358 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Analgesia
2.	Induced Hypothermia
3.	Hepatectomy
4.	Drug Therapy (Chemotherapy)
5.	Induced Hyperthermia (Thermotherapy)
6 Therapies and Procedures and 18 more articles analyzed in the Research Interface, order at left...